SciNeuro Pharmaceuticals
Lisa Li currently serves as Senior Vice President and Head of China Clinical at SciNeuro Pharmaceuticals, a position held since September 2021. Prior experience includes roles as Science & Medical Affairs Director and Medical Science Director at Ferring Pharmaceuticals from February 2018 to September 2021, and various positions in clinical development at GSK R&D China, including Director of Infectious Disease, Immune-Inflammation & Dermatology. Earlier in their career, Lisa Li worked at Bristol-Myers Squibb as Regional Disease Area Head for Virology and at Huashan Hospital, Fudan University as a physician. Lisa Li obtained a Ph.D. in Infectious Disease, a Master of Science in Infectious Disease, and a degree in Clinical Medicine, all from Fudan University. Additionally, Lisa Li completed a Postdoctoral Associate position in the Pharmacology Department at Yale University from August 2001 to December 2003.
SciNeuro Pharmaceuticals
SciNeuro Pharmaceuticals is a biopharmaceutical company focused on neuroscience that has an established pipeline of novel therapeutic candidates to treat neurodegenerative and other CNS diseases. It focuses on targets that are supported by human biology and play an important role in regulating foundation biology in order to increase the likelihoodof success in clinical development. SciNeuro is dedicated to delivering medicines that can make a difference in the lives of patients all over the world, transforming scientific discoveries into game-changing therapies.